Skip to main content

Home

  • Home
  • Hot
  • New
  • Opinions
  • Media
    • The Times of Israel
    • The Yeshiva World
    • Voz Iz Neias
    • Matzav
  • Home
  • Novel Alzheimer’s drug gets full FDA approval, though efficacy and risk questioned
08 Jul

Novel Alzheimer’s drug gets full FDA approval, though efficacy and risk questioned

By admin 0 Comments

Leqembi is first medicine convincingly shown to modestly slow cognitive decline, but some experts say effect too subtle, note dangers

Details
Vote up!
Vote down!

Points: -8

Category: 
Israel & the Region
Alzheimer's disease
medicine
US Food and Drug Administration (FDA)
  • Log in or register to post comments

Author

anon

admin

Hot

  • IDF Releases Video of IAF Strikes on Iranian Missile Launchers Before Barrage
  • Sen. Ernst Praises Trump for Neutralizing Iran’s Nuclear Threat, Ensuring Middle East Safety
  • Trump: U.S. Strikes on Iran’s Key Nuclear Sites a “Spectacular Military Success”

User login

  • Create new account
  • Request new password

Recent comments

No comments available.